Human latent transforming growth factor beta binding protein 2,LTBP2 ELISA Kit

Code CSB-E11268h
Size 96T,5×96T,10×96T
Price Request a Quote or Start an on-line Chat
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* The sample kit cost can be deducted from your subsequent orders of 96T full size kits of the same analyte at 1/5 per kit, until depleted in 6 months. Apply now

Product Details

Target Name
latent transforming growth factor beta binding protein 2
Alternative Names
C14orf141 ELISA Kit; Chromosome 14 open reading frame 141 ELISA Kit; Latent TGF beta binding protein 2 ELISA Kit; Latent transforming growth factor beta binding protein 2 ELISA Kit; Latent-transforming growth factor beta-binding protein 2 ELISA Kit; LTBP 2 ELISA Kit; LTBP 3 ELISA Kit; LTBP-2 ELISA Kit; Ltbp2 ELISA Kit; LTBP2_HUMAN ELISA Kit; LTBP3 ELISA Kit; MSTP 031 ELISA Kit; MSTP031 ELISA Kit
Abbreviation
LTBP2
Uniprot No.
Species
Homo sapiens (Human)
Sample Types
serum, plasma, tissue homogenates, cell lysates
Detection Range
0.156 ng/mL-10 ng/mL
Sensitivity
0.039 ng/mL
Assay Time
1-5h
Sample Volume
50-100ul
Detection Wavelength
450 nm
Research Area
Signal Transduction
Assay Principle
quantitative
Measurement
Sandwich
Precision
Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
Linearity
To assess the linearity of the assay, samples were spiked with high concentrations of human LTBP2 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
SampleSerum(n=4)
1:1Average %89
Range %85-91
1:2Average %83
Range %80-86
1:4Average %99
Range %95-104
1:8Average %97
Range %91-103
Recovery
The recovery of human LTBP2 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample TypeAverage % RecoveryRange
Serum (n=5) 8782-93
EDTA plasma (n=4)9693-99
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
ng/mlOD1OD2AverageCorrected
102.793 2.799 2.796 2.643
51.969 1.904 1.937 1.784
2.51.106 1.131 1.119 0.966
1.250.634 0.654 0.644 0.491
0.6250.407 0.431 0.419 0.266
0.3120.333 0.339 0.336 0.183
0.1560.214 0.219 0.217 0.064
00.152 0.154 0.153
Troubleshooting
and FAQs
Storage
Store at 2-8°C. Please refer to protocol.
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx
Description

This Human LTBP2 ELISA Kit was designed for the quantitative measurement of Human LTBP2 protein in serum, plasma, tissue homogenates, cell lysates. It is a Sandwich ELISA kit, its detection range is 0.156 ng/mL-10 ng/mL and the sensitivity is 0.039 ng/mL.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
(From Uniprot)
May play an integral structural role in elastic-fiber architectural organization and/or assembly.
Gene References into Functions
  1. Results revealed that the expression of LTBP2 was upregulated in gastric cancer (GC) tissues and cell lines. Increased LTBP2 expression was associated with poor overall survival in patients with early-stage [tumor-node-metastasis (TNM) I/II] and late-stage (TNM III/IV) GC. Furthermore, silencing of LTBP2 effectively suppressed the proliferation, migration, invasion and epithelial-mesenchymal transition in GC cells. PMID: 29620158
  2. effects of both oxidative stress and LTBP2 knockdown on the extracellular matrix and apoptosis may be mediated by TGFbeta and BMP signaling pathway activation PMID: 29908281
  3. LTBP2 is a novel biomarker for the diagnosis of pancreatic cancer. PMID: 28669978
  4. Our data suggest that LTBP2 acts as an oncogene in head and neck squamous cell carcinoma development and progression PMID: 27281608
  5. knockdown of LTBP2 inhibits invasion and tumorigenesis in thyroid carcinoma cells. PMID: 27712597
  6. We identified one nonsense mutation (c.2421G>A, p.W807X) in LTBP2 in eight Indian families. Among the mutations identified W807X in LTBP2 represent novel mutations. PMID: 28384041
  7. The results showed that no deleterious mutations were found in coding regions of LTBP2 in patients with PCG, suggesting that it is not a causal gene for primary congenital glaucoma in the Han Chinese population. PMID: 27293371
  8. LTBP-2 and FGF-2 are co-localized in fibrotic human keloid and hypertrophic scar. PMID: 26644005
  9. LTBP-2 is a potent inhibitor of FGF-2 that may influence FGF-2 bioactivity during wound repair particularly in fibrotic tissues. PMID: 26263555
  10. LTBP2 was able to reduce phosphorylation of p65 at Serine 536, inhibit nuclear localization of active phosphorylated p65, and impair the p65 DNA-binding ability. This results in a consequential down-regulation of p65-related gene expression. PMID: 25974126
  11. LTBP-2 is an essential component for the formation of microfibril bundles in ciliary zonules. PMID: 24908666
  12. perlecan HS was not essential for latent transforming growth factor-beta-1 binding protein-2 deposition PMID: 24867584
  13. Overall the results indicate that LTBP-2 may have a negative regulatory role during elastic fiber assembly, perhaps in displacing elastin microassemblies from complexes with fibulin-5 and/or cell surface heparan sulfate proteoglycans. PMID: 24148803
  14. Increased plasma levels of LTBP2 and/or OPN are present in plasma up to 2 years prior to diagnosis of hepatocellular carcinoma. PMID: 24803312
  15. Some LTBP2 sequence variations can contribute to the etiology of primary open angle glaucoma (POAG) and pseudoexfoliation (PEX) glaucoma syndrome. PMID: 23401661
  16. No pathogenic variants are identified in the LTBP2 gene in a cohort of patients with primary congenital glaucoma. PMID: 23378721
  17. LTBP2 mutations were not found in the Turkish GLC3C-linked primary congenital glaucoma (PCG) family or in 94 British CYP1B1-negative PCG cases. PMID: 22924778
  18. LTBP-2, in response to tension stress, may negatively control the function of fibulin-5, thereby modulating the mechanism of oxytalan fiber coalescence. PMID: 22827404
  19. This study analyzed CYP1B1, LTBP2, and MYOC mutations in a cohort of primary congenital glaucoma patients from the United States, applying whole exome sequencing PMID: 23218701
  20. Promoter hypermethylation was found to be involved in LTBP-2 silencing. PMID: 22743615
  21. Data show that median level of latent TGF-beta binding protein (LTBP) in myocardial samples from heart failure patients was significantly elevated. PMID: 22515403
  22. LTBP2 mutations cause Weill-Marchesani and Weill-Marchesani-like syndrome and affect disruptions in the extracellular matrix. PMID: 22539340
  23. plasma levels of LTBP2 present a novel and powerful predictor of all-cause mortality, and particularly pulmonary death PMID: 22587491
  24. Demonstrate specific immunolocalization of fibrillin-1, MAGP-1, and LTBP-1 with elastin in the outer annulus fibrosus of the fetal human intravertebral disc. PMID: 21540769
  25. Novel homozygous mutations in the LTBP-2 gene segregated with the phenotype in each affected consanguineous family cause congenital megalocornea with zonular weakness and childhood lens-related secondary glaucoma. PMID: 22025892
  26. A proteomic approach for identification and localization of the pericellular components of chondrocytes PMID: 21698479
  27. This study provided evidence that the IL-17A-197 G/A and TGFR-beta2-875 A/G genotype is closely related to hemorrhage risk for patients with brain arteriovenous malformation. PMID: 21737283
  28. Latent transforming growth factor beta-binding proteins-2 and -3 inhibit the proprotein convertase 5/6A. PMID: 21700711
  29. Preliminary observations on compounds with mutations in both CYP1B1-LTBP2 suggest that the observed combinations are of no clinical significance and digenic inheritance is unlikely. PMID: 21081970
  30. A susceptibility locus was identified on chromosome 14q24.3-31.2. The candidate functional gene is LTBP2. A suggestive linkage for mandibular prognathism in a Han Chinese pedigree. PMID: 21041550
  31. Study suggests a role for LTBP2 in the structural stability of ciliary zonules, and growth and development of lens. PMID: 20617341
  32. Biallelic null LTBP2 mutations cause the ocular phenotype in both families and could lead to Marfan-like features in older children. PMID: 20179738
  33. The authors reported that the isolated microspherophakia (MIM 251750) is caused by a mutation in the LTBP2 gene. The results suggested a role for LTBP2 in the growth and development of lens, and structural stability of ciliary zonules. PMID: 20617341
  34. LTBP-2 can play a role in melanoma cell adhesion PMID: 12716902
  35. These results suggest a novel regulatory mechanism of elastic fiber assembly in which LTBP-2 regulates targeting of DANCE on suitable microfibrils to form elastic fibers. PMID: 17581631
  36. LTBP2 is a novel positional candidate gene in chromosome 14q quantitative trait locos for bone density variation and fracture. PMID: 18697872
  37. LTBP2 is essential for normal development of the anterior chamber of the eye, where it may have a structural role in maintaining ciliary muscle tone. PMID: 19361779
  38. Loss of function mutations in LTBP2 cause the congenital glaucoma. PMID: 19656777
  39. Extracellular matrix association of LTBP-2 in cultured human embryonic lung fibroblasts depends on a pre-formed fibrillin-1 network. PMID: 19681046

Show More

Hide All

Involvement in disease
Glaucoma 3, primary congenital, D (GLC3D); Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma (MSPKA); Weill-Marchesani syndrome 3 (WMS3)
Subcellular Location
Secreted, extracellular space, extracellular matrix.
Protein Families
LTBP family
Tissue Specificity
Expressed in the aorta (at protein level). Expressed in lung, weakly expressed in heart, placenta, liver and skeletal muscle.
Database Links

HGNC: 6715

OMIM: 251750

KEGG: hsa:4053

STRING: 9606.ENSP00000261978

UniGene: Hs.512776

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1